Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-16

Clinical Trial Update: Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study [Phase 2]

View source ↗

Summary

Phase 2 GPAC study evaluated strategies to promote tolerance to common allergens in high-risk children as a potential approach to prevent asthma; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma, Allergic Sensitization | Phase 2 | Status: COMPLETED | Results posted: 2013-12-16